title: The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine.
abstract: Hydrogen sulfide (H2S) has attracted interest as a gaseous mediator involved in diverse processes in the nervous system, particularly with respect to learning and memory. However, its therapeutic potential in Alzheimer disease (AD) is not fully explored. Therefore, the effects of H2S-releasing compounds against AD-like behavioural and biochemical abnormalities were investigated. Memory deficit was induced by intracerberoventicular injection of streptozotocin (STZ, 3 mg·kg(-1)). Animals were randomly assigned into 5 groups (12 rats each): normal control, STZ treated, and 3 drug-treated groups receiving naproxen, H2S-releasing naproxen (ATB-346), and diallyl trisulfide in 20, 32, 40 mg·kg(-1)·day(-1), respectively. Memory function was assessed by passive avoidance and T-maze tasks. After 21 days, hippocampal IL-6, malondialdehyde, reduced glutathione (GSH), asymmetric dimethylarginine (ADMA), and acetylcholinestrase activity were determined. ATB-346 and diallyl trisulfide ameliorated behavioural performance and reduced malondialdehyde, ADMA, and acetylcholinestrase activity while increasing GSH. This study demonstrates the beneficial effects of H2S release in STZ-induced memory impairment by modulation of neuroinflammation, oxidative stress, and cholinergic function. It also delineates the implication of ADMA to the cognitive impairment induced by STZ. These findings draw the attention to H2S-releasing compounds as new candidates for treating neurodegenerative disorders that have prominent oxidative and inflammatory components such as AD.
authors.affiliation: a Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Dalia K
authors.initials: DK
authors.lastname: Mostafa
authors.affiliation: b Department of Physiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Nesrine M
authors.initials: NM
authors.lastname: El Azhary
authors.affiliation: c Department of Biochemistry, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Rasha A
authors.initials: RA
authors.lastname: Nasra
mesh_terms: D000498:Allyl Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism; D060825:Cognitive Dysfunction / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control; D006862:Hydrogen Sulfide / Q000378:metabolism*; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control; D018836:Inflammation Mediators / Q000378:metabolism; D008297:Male; D018782:Maze Learning / Q000187:drug effects / Q000502:physiology; D009288:Naproxen / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D013311:Streptozocin / Q000633:toxicity*; D013440:Sulfides / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: C550692:2-(6-methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl ester; D000498:Allyl Compounds; D018836:Inflammation Mediators; D013440:Sulfides; C042577:diallyl trisulfide; D009288:Naproxen; D013311:Streptozocin; C018524:N,N-dimethylarginine; D001120:Arginine; D006862:Hydrogen Sulfide
keywords: ATB-34; ATB-346; Alzheimer disease; diallyl trisulfide; et trisulfure de di-allyle; hydrogen sulfide; maladie d’Alzheimer; neuro-inflammation; neuroinflammation; oxidative stress; stress oxydant; sulfure d’hydrogène